These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

825 related articles for article (PubMed ID: 23347865)

  • 1. Percutaneous transcatheter aortic valve closure successfully treats left ventricular assist device-associated aortic insufficiency and improves cardiac hemodynamics.
    Parikh KS; Mehrotra AK; Russo MJ; Lang RM; Anderson A; Jeevanandam V; Freed BH; Paul JD; Karol J; Nathan S; Shah AP
    JACC Cardiovasc Interv; 2013 Jan; 6(1):84-9. PubMed ID: 23347865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of survival following trans-catheter aortic valve closure for left ventricular assist device associated aortic insufficiency.
    Retzer EM; Sayer GT; Fedson SE; Nathan S; Jeevanandam V; Friant J; Uriel N; Lang RM; Russo MJ; Shah AP
    Catheter Cardiovasc Interv; 2016 Apr; 87(5):971-9. PubMed ID: 26527571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous aortic valve closure for patients with left ventricular assist device-associated aortic insufficiency.
    Alkhouli M; Melito B; Ling FS
    Catheter Cardiovasc Interv; 2016 Dec; 88(7):1170-1173. PubMed ID: 26514340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical correction of aortic valve insufficiency after left ventricular assist device implantation.
    Atkins BZ; Hashmi ZA; Ganapathi AM; Harrison JK; Hughes GC; Rogers JG; Milano CA
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1247-52. PubMed ID: 23870154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous closure of the aortic valve as a bridge to heart transplantation to treat severe aortic insufficiency after ventricular assist device.
    Sauer AJ; Davidson CJ; McGee EC
    Catheter Cardiovasc Interv; 2015 Aug; 86(2):E103-6. PubMed ID: 24975484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accurate Quantification Methods for Aortic Insufficiency Severity in Patients With LVAD: Role of Diastolic Flow Acceleration and Systolic-to-Diastolic Peak Velocity Ratio of Outflow Cannula.
    Grinstein J; Kruse E; Sayer G; Fedson S; Kim GH; Jorde UP; Juricek C; Ota T; Jeevanandam V; Lang RM; Uriel N
    JACC Cardiovasc Imaging; 2016 Jun; 9(6):641-51. PubMed ID: 26684975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Durability of central aortic valve closure in patients with continuous flow left ventricular assist devices.
    McKellar SH; Deo S; Daly RC; Durham LA; Joyce LD; Stulak JM; Park SJ
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):344-8. PubMed ID: 23246052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First report of a simultaneous transcatheter mitral valve-in-valve and aortic valve replacement in a left ventricular assist device patient.
    Meduri C; Kauten J; Vannan M; Rajagopal V
    Catheter Cardiovasc Interv; 2017 Sep; 90(3):526-529. PubMed ID: 28295972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous treatment of severe aortic insufficiency in a patient with left ventricular assist device: friend or foe.
    Zacharias M; Dhingra R
    JACC Cardiovasc Interv; 2015 Apr; 8(5):750-1. PubMed ID: 25946449
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of severe aortic regurgitation in a patient with cardiogenic shock using a percutaneous left ventricular assist device and transcatheter occlusion of the failed aortic valve homograft as a bridge to surgical valve replacement.
    Pollak P; Lim DS; Kern J
    Catheter Cardiovasc Interv; 2014 Jan; 83(1):E141-5. PubMed ID: 23674479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous transcatheter closure of the native aortic valve to treat de novo aortic insufficiency after implantation of a left ventricular assist device.
    Freed BH; Paul JD; Bhave NM; Russo MJ; Jeevanandam V; Lang RM; Shah AP
    JACC Cardiovasc Interv; 2012 Mar; 5(3):358-9. PubMed ID: 22440504
    [No Abstract]   [Full Text] [Related]  

  • 12. Percutaneous transcatheter closure of the aortic valve to treat cardiogenic shock in a left ventricular assist device patient with severe aortic insufficiency.
    Russo MJ; Freed BH; Jeevanandam V; Hashmi M; Paul JD; Anderson A; Lang RM; Shah AP
    Ann Thorac Surg; 2012 Sep; 94(3):985-8. PubMed ID: 22916753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of percutaneous paravalvular regurgitation closure after transcatheter aortic valve replacement: a multicenter experience.
    Saia F; Martinez C; Gafoor S; Singh V; Ciuca C; Hofmann I; Marrozzini C; Tan J; Webb J; Sievert H; Marzocchi A; O'Neill WW
    JACC Cardiovasc Interv; 2015 Apr; 8(5):681-8. PubMed ID: 25946440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history and clinical effect of aortic valve regurgitation after left ventricular assist device implantation.
    Rajagopal K; Daneshmand MA; Patel CB; Ganapathi AM; Schechter MA; Rogers JG; Milano CA
    J Thorac Cardiovasc Surg; 2013 May; 145(5):1373-9. PubMed ID: 23312101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVR.
    Martinez CA; Singh V; O'Neill BP; Alfonso CE; Bilsker MS; Martinez Clark P; Williams D; Cohen MG; Heldman AW; O'Neill WW
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):300-11. PubMed ID: 23580318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and durability of central oversewing for treatment of aortic insufficiency in patients with continuous-flow left ventricular assist devices.
    Schechter MA; Joseph JT; Krishnamoorthy A; Finet JE; Ganapathi AM; Lodge AJ; Milano CA; Patel CB
    J Heart Lung Transplant; 2014 Sep; 33(9):937-42. PubMed ID: 24997496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous Transcatheter Interventions for Aortic Insufficiency in Continuous-Flow Left Ventricular Assist Device Patients: A Systematic Review and Meta-Analysis.
    Phan K; Haswell JM; Xu J; Assem Y; Mick SL; Kapadia SR; Cheung A; Ling FS; Yan TD; Tchantchaleishvili V
    ASAIO J; 2017; 63(2):117-122. PubMed ID: 27676407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transapical transcatheter aortic valve for severe aortic regurgitation: expanding the limits.
    Wendt D; Kahlert P; Pasa S; El-Chilali K; Al-Rashid F; Tsagakis K; Dohle DS; Erbel R; Jakob H; Thielmann M
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1159-67. PubMed ID: 25129668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CoreValve degeneration with severe transvalvular aortic regurgitation treated with valve-in-valve implantation.
    Sinning JM; Vasa-Nicotera M; Werner N; Zimmer S; Mellert F; Welz A; Grube E; Nickenig G; Hammerstingl C
    JACC Cardiovasc Interv; 2014 Jul; 7(7):e71-2. PubMed ID: 24954574
    [No Abstract]   [Full Text] [Related]  

  • 20. Aortic insufficiency in patients with sustained left ventricular systolic dysfunction after axial flow assist device implantation.
    Imamura T; Kinugawa K; Fujino T; Inaba T; Maki H; Hatano M; Kinoshita O; Nawata K; Kyo S; Ono M
    Circ J; 2015; 79(1):104-11. PubMed ID: 25381791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.